Certified by Founder Lodge
Junevity
United States - San Francisco, CA
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Junevity is a longevity biotechnology company developing Cell Reset therapeutics. The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targ
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 28 ,2025 | Seed | $10,000,000 |
Goldcrest Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Avitia | $5,000,000 | (Feb 28, 2025)
VerAI Discoveries | $24,000,000 | (Feb 28, 2025)
Gripp | $1,500,000 | (Feb 28, 2025)
Digit | $2,500,000 | (Feb 28, 2025)
Arsenale Bioyards | $10,000,000 | (Feb 28, 2025)
